Literature DB >> 28651150

Cognitive remediation improves executive functions, self-regulation and quality of life in residents of a substance use disorder therapeutic community.

Ely M Marceau1, Jamie Berry2, Joanne Lunn3, Peter J Kelly1, Nadia Solowij4.   

Abstract

BACKGROUND: Executive dysfunction is common in substance use disorder (SUD) populations and hinders treatment. We previously found that 50% of residents in SUD therapeutic communities had been hospitalized for head injuries; this was a significant determinant of cognitive impairment. The current study aimed to establish whether cognitive remediation improves executive functions (EFs) and self-regulation in an ecologically valid sample of female residents attending SUD therapeutic community treatment, including those with past head injuries and psychiatric comorbidities.
METHODS: Controlled sequential groups design with residents (N=33, all female) receiving treatment as usual (TAU). The intervention group (n=16) completed four weeks of cognitive remediation (CR) and the control, TAU only (n=17). Outcome measures assessed pre- and post-intervention included both performance- and inventory-based measures of EFs, and self-reported self-regulation and quality of life.
RESULTS: CR relative to TAU significantly improved performance-based assessment of inhibition (Color-Word Interference Test; F=4.29, p=0.047), inventory-based assessment of EFs (Behavior Rating Inventory of Executive Function - Adult Version: Global Executive Composite; F=6.38, p=0.017), impulsivity (Barratt Impulsiveness Scale; F=4.61, p=0.040), self-control (Brief Self-Control Scale; F=5.53, p=0.026), and quality of life (Quality of Life Enjoyment and Satisfaction Questionnaire - Short Form; F=7.68, p=0.010).
CONCLUSIONS: Findings suggest that CR improves EFs in a heterogeneous sample of female residents in therapeutic community SUD treatment. Future research may explore the possibility of tailoring CR interventions for various SUD subgroups.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cognitive remediation; Executive functions; Self-regulation; Substance use disorder; Therapeutic community

Mesh:

Year:  2017        PMID: 28651150     DOI: 10.1016/j.drugalcdep.2017.04.023

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  8 in total

1.  Development of Goal Management Training+ for Methamphetamine Use Disorder Through Collaborative Design.

Authors:  Alexandra C Anderson; Alex H Robinson; Eden Potter; Bronte Kerley; Daphne Flynn; Dan I Lubman; Antonio Verdejo-García
Journal:  Front Psychiatry       Date:  2022-04-25       Impact factor: 5.435

Review 2.  Cognitive Remediation as an Adjunct Treatment for Substance Use Disorders: A Systematic Review.

Authors:  Talia Nardo; Jennifer Batchelor; Jamie Berry; Heather Francis; Deyyan Jafar; Thomas Borchard
Journal:  Neuropsychol Rev       Date:  2021-04-19       Impact factor: 7.444

3.  Neurocognitive Empowerment for Addiction Treatment (NEAT): study protocol for a randomized controlled trial.

Authors:  Hamed Ekhtiari; Tara Rezapour; Brionne Sawyer; Hung-Wen Yeh; Rayus Kuplicki; Mimi Tarrasch; Martin P Paulus; Robin Aupperle
Journal:  Trials       Date:  2021-05-07       Impact factor: 2.279

4.  A stepped wedge cluster randomised trial of a cognitive remediation intervention in alcohol and other drug (AOD) residential treatment services.

Authors:  Jamie Berry; Isabella Jacomb; Jo Lunn; Antoinette Sedwell; Anthony Shakeshaft; Peter J Kelly; Pooria Sarrami; Megan James; Skye Russell; Talia Nardo; Daniel Barker; Jennifer Holmes
Journal:  BMC Psychiatry       Date:  2019-02-13       Impact factor: 3.630

Review 5.  A Roadmap for Integrating Neuroscience Into Addiction Treatment: A Consensus of the Neuroscience Interest Group of the International Society of Addiction Medicine.

Authors:  Antonio Verdejo-Garcia; Valentina Lorenzetti; Victoria Manning; Hugh Piercy; Raimondo Bruno; Rob Hester; David Pennington; Serenella Tolomeo; Shalini Arunogiri; Marsha E Bates; Henrietta Bowden-Jones; Salvatore Campanella; Stacey B Daughters; Christos Kouimtsidis; Dan I Lubman; Dieter J Meyerhoff; Annaketurah Ralph; Tara Rezapour; Hosna Tavakoli; Mehran Zare-Bidoky; Anna Zilverstand; Douglas Steele; Scott J Moeller; Martin Paulus; Alex Baldacchino; Hamed Ekhtiari
Journal:  Front Psychiatry       Date:  2019-12-23       Impact factor: 4.157

6.  Study protocol the Continuing Care Project: a randomised controlled trial of a continuing care telephone intervention following residential substance dependence treatment.

Authors:  Peter Kelly; Frank Deane; Gerard Byrne; Tayla Degan; Briony Osborne; Camilla Townsend; James McKay; Laura Robinson; Christopher Oldmeadow; Kenny Lawson; Andrew Searles; Joanne Lunn
Journal:  BMC Public Health       Date:  2020-01-28       Impact factor: 3.295

7.  Protocol for a cluster randomised crossover pilot trial of Goal Management Training+ (GMT+) for methamphetamine use disorder.

Authors:  Alexandra C Anderson; Alex H Robinson; Dan I Lubman; Antonio Verdejo-Garcia
Journal:  Contemp Clin Trials Commun       Date:  2022-08-11

8.  Artificial Cognitive Systems Applied in Executive Function Stimulation and Rehabilitation Programs: A Systematic Review.

Authors:  Luis F Castillo-Ossa; Juan M Corchado; Carolina Robledo-Castro
Journal:  Arab J Sci Eng       Date:  2022-09-28       Impact factor: 2.807

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.